epeat acute myocardial infarction (AMI) is a deteriorated condition with high in-hospital morbidity and mortality, which can be attributed to the frequent coexistence of multivessel disease and shock. Previous accumulating evidence shows that primary percutaneous coronary intervention (PCI) can improve the prognosis of AMI complicated with cardiogenic shock, 1-4 although a recent report indicated that previous myocardial infarction (MI), older age, and failed reperfusion were independent predictors of in-hospital death in AMI patients with cardiogenic shock. 5 However, the clinical manifestations and the predictors of in-hospital prognosis of repeat AMI patients Circulation Journal Vol.72, August 2008 undergoing primary PCI remain to be elucidated. The AMIKyoto Multi-Center Risk Study, a large multicenter observational study in which 16 collaborating hospitals in Kyoto Prefecture have collected demographic, procedural, and outcome data on AMI patients, was established in 2000 in order to analyze these data and establish an emergencyhospital network for heart diseases in Kyoto. [6] [7] [8] [9] The purpose of the present study was to compare clinical background, in-hospital prognosis, and determinants of in-hospital outcome in recurrent AMI patients undergoing primary PCI with those of first AMI patients undergoing primary PCI, using data from the AMI-Kyoto Multi-Center Risk Study.
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risk factors, angiographic findings, acute results of primary PCI, and in-hospital prognosis between primary PCI-treated patients with previous MI (repeat MI group, n=235) and those without previous MI (first MI group, n=1,550). The diagnosis of AMI required the presence of 2 of the following 3 criteria: (1) characteristic clinical history, (2) serial changes on the ECG suggesting infarction (Q-waves) or injury (ST-segment elevations), and (3) transient increase in cardiac enzymes to more than 2-fold the normal laboratory value.
Data Collection
The patients' demographic information, cardiovascular history, and risk factors (ie, smoking, hypercholesterolemia, hypertension, and diabetes mellitus) were recorded. Hypercholesterolemia was defined as total cholesterol ≥220 mg/dl or the use of cholesterol-lowering agents; hypertension was defined as systemic blood pressure ≥140/90 mmHg or the use of antihypertensive treatment; diabetes mellitus was defined as fasting blood sugar ≥126 mg/dl or the use of specific treatment. After informed consent to participate in the AMI-Kyoto Multi-Center Risk Study was confirmed by each patient, all in-hospital data were transmitted to the center located at the Department of Cardiology and Vascular Regenerative Medicine in Kyoto Prefectural University School of Medicine for analysis. The study protocol was approved by each hospital's ethics committee.
Emergency Coronary Angiography (CAG) and Reperfusion Therapy
Emergency CAG was performed using the standard technique. The coronary flow in the infarct-related artery was graded according to the classification used in the Thrombolysis In Myocardial Infarction (TIMI) trial. Significant coronary artery stenosis was defined as at least 75% reduction in the internal diameter of the right, left anterior descending, or left circumflex coronary arteries and their major branches, or 50% reduction in the internal diameter of the left main trunk (LMT). Non-significant stenosis was defined as coronary arterial narrowing less than a significant stenosis. Patients with either angiographically normal coronary arteries or non-significant stenosis were classified as having zero-vessel disease. Multivessel disease as the culprit lesion was defined as simultaneous thromboses of multiple coronary arteries on initial CAG. After the culprit lesions were ascertained by CAG, primary PCI was subsequently performed.
Statistical Analysis
Data are expressed as mean ± SD. The repeat MI and the first MI groups were compared using the chi-square test for discrete variables and unpaired Student's t-test for continuous variables according to standard statistical methods. The odds ratio and 95% confidence intervals assessing the risk of in-hospital death were estimated by multivariate logistic regression analysis. In the multivariate logistic regression analysis, TIMI flow grade was categorized into 2 groups: grade 3 and grade ≤2 or unknown. In all analyses, significance was accepted at p<0.05.
Results

Patient Characteristics and Risk Factors
The clinical characteristics and risk factors in the 2 groups are summarized in Table 1 . The repeat-MI group had higher frequency of males, previous PCI, previous coronary artery bypass grafting (CABG), and Killip class ≥3 on admission, compared with the first-MI group. The prevalence of coronary risk factors did not differ between the 2 groups, although the repeat-MI group tended to have a higher frequency of diabetes mellitus, but not significantly. Table 2 shows the emergency CAG data for the 2 groups. The repeat-MI group had a larger number of diseased vessels than the first-MI group, but the prevalence of culprit lesions did not vary between groups. Table 3 shows the results of primary PCI in the 2 groups. Data on TIMI grade were available in 217 of the 235 repeat-MI patients and in 1,384 of the 1,550 first-MI patients. The distribution of TIMI grade before and after primary PCI did not differ significantly between the 2 groups. The repeat-MI group had a higher rate of intra-aortic balloon pumping (IABP) than the first-MI group. Table 4 shows the in-hospital prognoses in the 2 groups. The repeat-MI group had a significantly higher in-hospital overall mortality rate than the first-MI group. The repeat-MI group had slightly, but not significantly higher prevalence of cardiac-related death, and a significantly higher incidence of noncardiac-related death, compared with the first-MI group. The length of hospital stay and the maximum creatine phosphokinase concentration did not differ between the 2 groups. In order to assess the contribution of clinical background, risk factors, angiographic findings, and results of primary PCI, multivariate logistic regression analysis using all available variables (age, gender, previous PCI, previous CABG, smoking, hypercholesterolemia, hypertension, diabetes mellitus, multivessel or LMT as culprit lesion, number of diseased vessels ≥2 or diseased LMT, stent usage, elapsed time <24 h, Killip class ≥3 at admission, TIMI 3 flow before/after primary PCI) was developed for overall death during hospitalization in the repeat-MI group as well as in the first-MI group (Table 5) . Killip class ≥3 at admission and age were the independent positive predictors of in-hospital mortality in both groups. The presence of multivessel or LMT as culprit lesion was the independent positive predictor of in-hospital mortality in the first-MI group, but not in the repeat-MI group. Achieving of TIMI 3 flow just after primary PCI and elapsed time <24 h were the negative predictors in the first-MI group, but not in the repeat MI group. In contrast, the number of diseased vessels ≥2 or diseased LMT was an independent positive predictor of inhospital mortality in the repeat-MI group, but not in the first-MI group.
Angiographic Data
Results of Coronary Intervention
In-Hospital Outcomes
Discussion
The major findings of the present multicenter study are as follows: in AMI patients undergoing primary PCI, the number of diseased vessels ≥2 or diseased LMT on initial CAG was an independent positive predictor of in-hospital mortality in repeat-MI patients, but not in first-MI patients; achieving of TIMI 3 flow immediately after primary PCI and elapsed time <24 h were independent negative predictors in first-MI patients, but not in repeat-MI patients.
This study is the first to investigate the clinical manifestations and determinants of in-hospital outcome in recurrent AMI patients undergoing primary PCI. In the present report, repeat-MI patients had higher prevalence of being male, prior percutaneous/surgical revascularizations, and Killip class ≥3 at admission, larger number of diseased vessels on initial CAG, higher frequency of IABP during primary PCI, and a significantly higher in-hospital mortality rate, compared with the first-MI patients, although TIMI flow grade in the infarct-related artery before/after primary PCI did not differ between the repeat-MI patients and the first-MI patients. Hemodynamic instability and residual myocardial Tables 1-3 .
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ischemia derived from their clinical backgrounds might be associated with the higher in-hospital mortality in the repeat-MI patients. In the present report, the repeat-MI patients had a slightly, but not significantly higher prevalence of cardiac-related death, but a significantly higher incidence of noncardiac-related death, compared with the first-MI patients. However, we cannot rule out the possibility that cardiac impairments might have influenced the clinical course of the noncardiac diseases in the repeat-MI patients. Thus, there is a possibility that revascularization therapy in the infarct-related artery alone might be an inadequate strategy for improving the in-hospital outcome in repeat-MI patients with multivessel disease. The present report has demonstrated for the first time that the number of diseased vessels ≥2 or diseased LMT on initial CAG was an independent positive predictor of inhospital mortality in the recurrent-MI patients undergoing primary PCI, but not in the first-MI patients. In contrast, acquisition of TIMI 3 flow in the infarct-related artery just after primary PCI was not an independent negative predictor in the repeat-MI patients, but was in the first-MI patients. These inconsistent data suggest that for the repeat-MI patients with multivessel disease, primary PCI in the infarctrelated artery alone might be insufficient and additional IABP, multivessel PCI or early staged PCI should be considered in order to improve the in-hospital prognosis. However, according to the guidelines for PCI published by the American Heart Association, the American College of Cardiology, and the Society for Cardiovascular Angiography and Interventions in 2005, PCI should not be performed in a non-infarct-related coronary artery at the time of primary PCI of the infarct-related artery in AMI patients without hemodynamic compromise. 10 Multivessel PCI might require larger amounts of contrast, leading to contrast-induced nephropathy. In addition, there is a possibility that acute closure, no or slow reflow, or vasospasm in a non-infarctrelated coronary artery during primary PCI could result in a critical condition such as cardiogenic shock. Therefore, early staged PCI for the non-infarct-related coronary artery under sufficient medication, such as antiplatelet drugs, statins, and vasodilators, might be a more suitable therapy for recurrent AMI patients with multivessel disease, compared with multivessel PCI during primary PCI. On the other hand, based on our data, for first-MI patients, primary PCI for the infarct-related artery alone is an appropriate strategy.
Previous and recent reports have indicated that approximately 50% of patients presenting with AMI have multivessel coronary artery disease, and even in the primary PCI era, those patients have a higher risk of in-hospital death. 9, 11, 12 However, the role of multivessel PCI or early staged PCI in AMI patients with multivessel disease during the index hospital stay remains controversial. [13] [14] [15] A recent report from Corpus et al indicated that in AMI patients with multivessel disease, multivessel PCI was associated with higher frequency of re-infarction, revascularization, and major adverse cardiac events (MACE), compared with PCI restricted to the infarct-related artery alone, suggesting that in AMI patients with multivessel disease, PCI should be performed for the infarct-related artery alone during the index hospital stay. 13 In contrast, another recent report has shown that in AMI patients with multivessel disease, multivessel PCI was not associated with additional death and MACE, compared with PCI in the infarct-related artery alone, 14 and another recent study has also pointed out that incomplete revascularization was a significant and independent risk of death and MACE, particularly in AMI patients with lowered ejection fraction, impaired renal function, or diabetes mellitus. 15 Our study has also demonstrated that the presence of multivessel disease or diseased LMT on initial CAG was an independent positive predictor of in-hospital death in the repeat-MI patients, a subgroup of high-risk patients with AMI, but not in the first-MI patients. Further prospective and long-term follow-up studies are necessary to ascertain the determinants of prognosis in patients with recurrent MI and to evaluate the safety and efficacy of multivessel PCI or early staged PCI in this population.
Study Limitations
First, this was a retrospective observational analysis of a relatively small number of patients. Second, data on clinical background and angiographic results of primary PCI were not available for all AMI patients undergoing primary PCI. Third, we have not accounted for left ventricular function and door-to-balloon time, which might be a predicting risk of in-hospital death. Fourth, "ST-elevation MI" was not discriminated from "non-ST-elevation MI".
Conclusion
The present study provides evidence that the number of diseased vessels ≥2 or diseased LMT on initial CAG is an independent risk factor of in-hospital death in recurrent-MI patients undergoing primary PCI. However, the relatively small sample size of our report is a major limitation and a larger study should be performed to confirm our findings.
